A Multi-Center, Open-Label, Parallel-Arm, Randomized, Dose-Ranging Study of ENV515 (travoprost) Intracameral Implant in Subjects with Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma
Research Grant
Administered By
Ophthalmology
Awarded By
Envisia Therapeutics
Start Date
January 20, 2015
End Date
January 19, 2020
Administered By
Ophthalmology
Awarded By
Envisia Therapeutics
Start Date
January 20, 2015
End Date
January 19, 2020